Back to top
more

Molina Healthcare (MOH)

(Delayed Data from NYSE)

$190.71 USD

190.71
1,473,441

+8.15 (4.46%)

Updated Sep 24, 2025 04:00 PM ET

After-Market: $190.71 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (234 out of 246)

Industry: Medical - HMOs

Zacks News

Zacks Equity Research

Coupa Partners Solmate to Foray in to the Benelux Region

Coupa Software (COUP) recently announced a partnership with the Netherlands based Solmate that will help it to penetrate the Benelux region.

    Zacks Equity Research

    Health Insurers Hit 52-Week Highs: What's Behind the Rise?

    The rally in the stock is believed to be have occurred from the repeal and replace plan unveiled by the Trump administration.

      Zacks Equity Research

      Will Health Insurers Win Under Obamacare Replacement Plan?

      While retaining the pre-existing conditions clause might hinder health insurers' business, their ability to charge a penalty on those who fail to maintain coverage is being seen as a positive.

        Zacks Equity Research

        Molina Healthcare (MOH) Issues Revised Q4 & 2016 Results

        Molina Healthcare, Inc. (MOH) recently issued revised fourth quarter and full-year 2016 results.

          Zacks Equity Research

          Molina Healthcare (MOH) Q4 Earnings, Revenues Miss Estimates

          Molina Healthcare Inc. (MOH) reported fourth-quarter 2016 adjusted net income per share of 63 cents, missing the Zacks Consensus Estimate of 75 cents by 16%.

            Zacks Equity Research

            Why Earnings Season Could Be Great for Molina Healthcare (MOH)

            Investors are always looking for stocks that are poised to beat at earnings season and Molina Healthcare, Inc. (MOH) may be one such company.

              Zacks Equity Research

              Zacks Industry Outlook Highlights: Molina Healthcare, Centene, WellCare Health Plans and UnitedHealth Group

              Zacks Industry Outlook Highlights: Molina Healthcare, Centene, WellCare Health Plans and UnitedHealth Group

                Zacks Equity Research

                Will Health Insurers Face the Music of Trump's Policies?

                After having adjusted to tthe ACA policy, insurers might have to reassess their business strategies in the wake of the Trump presidency.

                  Zacks Equity Research

                  4 Healthcare Players Likey to Trump Q4 Earnings Estimates

                  Trump's victory has sent waves across the Healthcare industry.

                    Zacks Equity Research

                    Can Humana (HUM) Pull a Surprise This Earnings Season?

                    Humana Inc. (HUM) will release fourth-quarter 2016 results on Feb 8, before the market opens.

                      Zacks Equity Research

                      Marsh & McLennan (MMC): Will it Disappoint in Q4 Earnings? (Revised)

                      Marsh & McLennan Companies, Inc. (MMC) is scheduled to report fourth-quarter and full-year 2016 results on Feb 2.

                        Zacks Equity Research

                        Can Cigna (CI) Sustain its Earnings Surprise Streak in Q4? (Revised)

                        We expect Cigna Corp. (CI) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Feb 2.

                          Zacks Equity Research

                          Marsh & McLennan (MMC): Will it Disappoint in Q4 Earnings?

                          Marsh & McLennan Companies, Inc. (MMC) is scheduled to report fourth-quarter and full-year 2016 results on Feb 2.

                            Zacks Equity Research

                            Can Cigna (CI) Sustain its Earnings Surprise Streak in Q4?

                            We expect Cigna Corp. (CI) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Feb 2.

                              Zacks Equity Research

                              Is a Beat in the Cards for Allstate's (ALL) Q4 Earnings?

                              We expect Allstate Corporation (ALL) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Feb 1,

                                Zacks Equity Research

                                Aetna (AET) Earnings Beat Estimates in Q4, Revenues Miss

                                Aetna's (AET) earnings of $1.63 per share, surpassing the Zacks Consensus Estimate of $1.45 and improving 19% year over year.

                                  Zacks Equity Research

                                  What's in Store for Metlife (MET) this Earnings Season?

                                  MetLife, Inc. (MET) is scheduled to report fourth-quarter and full-year 2016 results on Feb 1, after market close.

                                    Zacks Equity Research

                                    Lincoln National (LNC) Q4 Earnings: A Beat in the Cards?

                                    We expect Lincoln National Corp. (LNC) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Feb 1, after market close.

                                      Zacks Equity Research

                                      Teladoc (TDOC) to Report Q4 Earnings: What's in Store? (revised)

                                      Telehealth provider Teladoc Inc. (TDOC) has not confirmed the time/date for its December-quarter earnings release yet, but the report will likely be fairly soon, as they last reported quarterly results on October 27, 2016.

                                        Zacks Equity Research

                                        Becton, Dickinson (BDX) Q1 Earnings: What's in the Cards?

                                        Becton, Dickinson and Company (BDX) is set to report first-quarter fiscal 2017 earnings results on Feb 2.

                                          Zacks Equity Research

                                          Why HCA Holdings (HCA) is Likely to Beat on Earnings in Q4

                                          We expect HCA Holdings Inc. (HCA) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Jan 31.

                                            Zacks Equity Research

                                            Will Aflac (AFL) Disappoint Investors this Earnings Season?

                                            Aflac Inc. (AFL) is scheduled to report fourth-quarter and full-year 2016 results on Jan 31 after the closing bell.

                                              Zacks Equity Research

                                              Anthem (ANTM) Q4 Earnings: A Beat in Store for the Stock?

                                              We expect Anthem Inc. (ANTM) to beat expectations when it reports fourth-quarter results on Feb 1 before the market opens.

                                                Zacks Equity Research

                                                Is Disappointment in Store for Aetna (AET) in Q4 Earnings?

                                                Aetna Inc. (AET) is scheduled to report fourth-quarter and full-year 2016 results on Jan 31 before the opening bell.

                                                  Zacks Equity Research

                                                  Will PerkinElmer (PKI) Disappoint this Earnings Season?

                                                  PerkinElmer Inc. (PKI) is expected to report fourth-quarter 2016 results on Feb 2, 2017.